Unveiled at Galaxy Unpacked, the new lineup includes sleep apnea detection, vascular stress monitoring and the first ...

Constant Therapy , a digital health company specializing in speech-language Therapy, is collaborating with Burke Rehabilitation to launch an AI-powered post-acute speech therapy program for patients ...

OpenEvidence , an AI-enabled medical research aggregate platform for doctors, has scored $210 million in Series B funding, boosting the company's valuation to $3.5 billion. The round was co-led by ...

The news comes alongside the U.S. Department of Defense’s announcement of $200 million contracts awarded to xAI, Anthropic, Google and OpenAI for AI implementation.

Arnaub Chatterjee, Datavant president and GM of life sciences, says the company will streamline data linking and evidence generation across real-world and clinical trial data.

The company will use the funds to move into the female health space and increase screening and preventive care.

The funds will be used to increase the development of GAIA-based Alzheimer's Disease drugs and widen the pipeline of blockbuster drug candidates.

NEW YORK - At HIMSS AI Forum on Friday, during the talk, "The future of people centered care: earning (or losing) trust by leveraging AI and synthetic research," Dr. Adrienne Boissy, chief medical ...

The Focalist system aims to combine handheld robotics with real-time imaging to enable clinicians to place needles more ...

The organizations will co-develop AI playbooks, tools, a new certification program and best practices for health AI.

Phil, a company focused on pharmaceutical commercialization, has secured $60 million in growth debt financing from K2 HealthVentures. The company's PhilRx platform provides prescription services to ...

A new AI algorithm developed by researchers from the University of Western Australia has been found to better predict the ...